Temitope Keku, MSPH, PhD has published a review in The American Journal of Physiology—Gastrointestinal and Liver Physiology titled “The Gastrointestinal Microbiota and Colorectal Cancer.” Coauthors include Drs. Santosh Dulal, April Deveaux, Biljana Jovov, and Xuesong Han. This article provides an overview on the role of resident gut microbiota in the development of human colorectal cancer and explores its association with diet and inflammation.
Ebix, Inc., today announced that the annual Ebix Charity Challenge, will be held in Greensboro, North Carolina on February 7, 2015. All proceeds from the 5th Annual Ebix Charity Challenge will benefit the UNC Lineberger Comprehensive Cancer Center, where America No. 1 John Isner’s mother, Karen, was successfully treated during her two battles with colon cancer.
UNC Lineberger members Joseph DeSimone, PhD and Jenny Ting, PhD, along with other researchers at the UNC-Chapel Hill and North Carolina State University have uncovered a novel approach to creating inhalable vaccines using nanoparticles that shows promise for targeting lung-specific diseases, such as influenza, pneumonia and tuberculosis. The findings, published in the Proceedings of the National Academy of Sciences, also have broad public health implications for improving the accessibility of vaccines.
Researchers at the UNC-Chapel Hill and North Carolina State University have uncovered a novel approach to creating inhalable vaccines using nanoparticles that shows promise for targeting lung-specific diseases, such as influenza, pneumonia and tuberculosis. The work was led by Cathy Fromen and Gregory Robbins, members of the DeSimone and Ting labs at UNC Lineberger, and reveals that a particle’s surface charge plays a key role in eliciting immune responses in the lung.
Carolina legend Danny Talbott performed at the highest level on both the football field and baseball diamond during his years as a Tar Heel. Since 2010, he’s been back in Chapel Hill, battling the toughest opponent he’s faced: multiple myeloma. He can’t imagine going anywhere else to do it.
UNC Lineberger Comprehensive Cancer Center member Jim Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine and director of clinical cancer genetics, has co-authored a commentary on proposed US Food and Drug Administration (FDA) regulation of genetic testing in the Journal of the American Medical Association (JAMA).
Deborah Mayer, Ph.D., R.N., AOCN, FAAN, Professor at the School of Nursing, Director of Cancer Survivorship at UNC Lineberger, is a national pioneer on research in cancer survivorship. Her work sheds light on the best ways to monitor and manage care for cancer survivors long after diagnosis and treatment. She is a staunch advocate for serving patients’ needs and the importance of good communication.
The UNC Cancer Pro Bono Project allows law students, working under the supervision of volunteer attorneys, to draw up advance directives for cancer patients, for free. Originally designed as a joint program with Duke, Carolina’s student-run program has grown so much that it operates independently now, with the help of Legal Aid of North Carolina Inc. and about 35 volunteer attorneys.